Correction: Tracking daratumumab clearance using mass spectrometry: implications on M protein monitoring and reusing daratumumab (Leukemia, (2022), 36, 5, (1426-1428), 10.1038/s41375-021-01501-0)

Nadine Abdallah; David Murray; Angela Dispenzieri; Prashant Kapoor; Morie A. Gertz; Martha Q. Lacy; Suzanne R. Hayman; Francis K. Buadi; Wilson Gonsalves; Eli Muchtar; Nelson Leung; David Dingli; Taxiarchis Kourelis; Rahma Warsame; Moritz Binder; Robert A. Kyle; S. Vincent Rajkumar; Shaji Kumar

doi:10.1038/s41375-022-01567-4

Correction: Tracking daratumumab clearance using mass spectrometry: implications on M protein monitoring and reusing daratumumab (Leukemia, (2022), 36, 5, (1426-1428), 10.1038/s41375-021-01501-0)

Nadine Abdallah, David Murray, Angela Dispenzieri, Prashant Kapoor, Morie A. Gertz, Martha Q. Lacy, Suzanne R. Hayman, Francis K. Buadi, Wilson Gonsalves, Eli Muchtar, Nelson Leung, David Dingli, Taxiarchis Kourelis, Rahma Warsame, Moritz Binder, Robert A. Kyle, S. Vincent Rajkumar, Shaji Kumar

Hematology

Research output: Contribution to journal › Comment/debate › peer-review

Abstract

We noted a mistake in the Introduction section in the following sentence: “and ability to differentiate therapeutic monoclonal antibodies from endogenous M proteins based on unique retention time and mass”. The use of mass and retention time is actually not true for the MALDI method. We would like to correct this sentence and replace it with: “with ability to aid in differentiating therapeutic monoclonal antibodies from endogenous M proteins on the basis of mass to charge.

Original language	English (US)
Pages (from-to)	1449
Number of pages	1
Journal	Leukemia
Volume	36
Issue number	5
DOIs	https://doi.org/10.1038/s41375-022-01567-4
State	Published - May 2022

ASJC Scopus subject areas

Hematology
Oncology
Cancer Research

Access to Document

10.1038/s41375-022-01567-4

Cite this

Abdallah, N., Murray, D., Dispenzieri, A., Kapoor, P., Gertz, M. A., Lacy, M. Q., Hayman, S. R., Buadi, F. K., Gonsalves, W., Muchtar, E., Leung, N., Dingli, D., Kourelis, T., Warsame, R., Binder, M., Kyle, R. A., Rajkumar, S. V., & Kumar, S. (2022). Correction: Tracking daratumumab clearance using mass spectrometry: implications on M protein monitoring and reusing daratumumab (Leukemia, (2022), 36, 5, (1426-1428), 10.1038/s41375-021-01501-0). Leukemia, 36(5), 1449. https://doi.org/10.1038/s41375-022-01567-4

Correction : Tracking daratumumab clearance using mass spectrometry: implications on M protein monitoring and reusing daratumumab (Leukemia, (2022), 36, 5, (1426-1428), 10.1038/s41375-021-01501-0). / Abdallah, Nadine; Murray, David; Dispenzieri, Angela et al.

In: Leukemia, Vol. 36, No. 5, 05.2022, p. 1449.

Research output: Contribution to journal › Comment/debate › peer-review

Abdallah, N, Murray, D, Dispenzieri, A , Kapoor, P , Gertz, MA , Lacy, MQ, Hayman, SR, Buadi, FK, Gonsalves, W, Muchtar, E, Leung, N, Dingli, D , Kourelis, T, Warsame, R, Binder, M, Kyle, RA, Rajkumar, SV & Kumar, S 2022, 'Correction: Tracking daratumumab clearance using mass spectrometry: implications on M protein monitoring and reusing daratumumab (Leukemia, (2022), 36, 5, (1426-1428), 10.1038/s41375-021-01501-0)', Leukemia, vol. 36, no. 5, pp. 1449. https://doi.org/10.1038/s41375-022-01567-4

@article{c639e3bd384848f3b71f656463845ae7,

title = "Correction: Tracking daratumumab clearance using mass spectrometry: implications on M protein monitoring and reusing daratumumab (Leukemia, (2022), 36, 5, (1426-1428), 10.1038/s41375-021-01501-0)",

abstract = "We noted a mistake in the Introduction section in the following sentence: “and ability to differentiate therapeutic monoclonal antibodies from endogenous M proteins based on unique retention time and mass”. The use of mass and retention time is actually not true for the MALDI method. We would like to correct this sentence and replace it with: “with ability to aid in differentiating therapeutic monoclonal antibodies from endogenous M proteins on the basis of mass to charge.",

author = "Nadine Abdallah and David Murray and Angela Dispenzieri and Prashant Kapoor and Gertz, {Morie A.} and Lacy, {Martha Q.} and Hayman, {Suzanne R.} and Buadi, {Francis K.} and Wilson Gonsalves and Eli Muchtar and Nelson Leung and David Dingli and Taxiarchis Kourelis and Rahma Warsame and Moritz Binder and Kyle, {Robert A.} and Rajkumar, {S. Vincent} and Shaji Kumar",

note = "Publisher Copyright: {\textcopyright} The Author(s) 2022.",

year = "2022",

month = may,

doi = "10.1038/s41375-022-01567-4",

language = "English (US)",

volume = "36",

pages = "1449",

journal = "Leukemia",

issn = "0887-6924",

publisher = "Nature Publishing Group",

number = "5",

}

TY - JOUR

T1 - Correction

T2 - Tracking daratumumab clearance using mass spectrometry: implications on M protein monitoring and reusing daratumumab (Leukemia, (2022), 36, 5, (1426-1428), 10.1038/s41375-021-01501-0)

AU - Abdallah, Nadine

AU - Murray, David

AU - Dispenzieri, Angela

AU - Kapoor, Prashant

AU - Gertz, Morie A.

AU - Lacy, Martha Q.

AU - Hayman, Suzanne R.

AU - Buadi, Francis K.

AU - Gonsalves, Wilson

AU - Muchtar, Eli

AU - Leung, Nelson

AU - Dingli, David

AU - Kourelis, Taxiarchis

AU - Warsame, Rahma

AU - Binder, Moritz

AU - Kyle, Robert A.

AU - Rajkumar, S. Vincent

AU - Kumar, Shaji

PY - 2022/5

Y1 - 2022/5

N2 - We noted a mistake in the Introduction section in the following sentence: “and ability to differentiate therapeutic monoclonal antibodies from endogenous M proteins based on unique retention time and mass”. The use of mass and retention time is actually not true for the MALDI method. We would like to correct this sentence and replace it with: “with ability to aid in differentiating therapeutic monoclonal antibodies from endogenous M proteins on the basis of mass to charge.

AB - We noted a mistake in the Introduction section in the following sentence: “and ability to differentiate therapeutic monoclonal antibodies from endogenous M proteins based on unique retention time and mass”. The use of mass and retention time is actually not true for the MALDI method. We would like to correct this sentence and replace it with: “with ability to aid in differentiating therapeutic monoclonal antibodies from endogenous M proteins on the basis of mass to charge.

UR - http://www.scopus.com/inward/record.url?scp=85127939469&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85127939469&partnerID=8YFLogxK

U2 - 10.1038/s41375-022-01567-4

DO - 10.1038/s41375-022-01567-4

M3 - Comment/debate

C2 - 35414658

AN - SCOPUS:85127939469

SN - 0887-6924

VL - 36

SP - 1449

JO - Leukemia

JF - Leukemia

IS - 5

ER -

Correction: Tracking daratumumab clearance using mass spectrometry: implications on M protein monitoring and reusing daratumumab (Leukemia, (2022), 36, 5, (1426-1428), 10.1038/s41375-021-01501-0)

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this